Advanced-Stage Colorectal Cancer in Persons Younger Than 50 Years Not Associated With Longer Duration of Symptoms or Time to Diagnosis

Clinical Gastroenterology and Hepatology

Volumn 15, Issue 5, 2017, Pages 728-737.e3

  Chen, Frank W ^a   Sundaram, Vandana ^a   Chew, Thomas A ^a   Ladabaum, Uri ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Colon Cancer; Detection; Epidemiology; Work Up

Indexed keywords

ADULT; ADVANCED CANCER; AGE; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CLINICAL FEATURE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DISEASE DURATION; FAMILY HISTORY; FEMALE; HEREDITARY TUMOR SYNDROME; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; RETROSPECTIVE STUDY; SYMPTOM; ADENOCARCINOMA; COLORECTAL TUMOR; INCIDENCE; MIDDLE AGED; PATHOLOGY; TIME FACTOR; UNITED STATES;

ADENOCARCINOMA; ADULT; AGED; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; TIME FACTORS; UNITED STATES;

EID: 85012907105     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2016.10.038     Document Type: Article

References (34)

1. 1 American Cancer Society. Colorectal cancer facts & figures 2014–2016. Atlanta, GA, American Cancer Society.
2. 2 Edwards, B.K., Ward, E., Kohler, B.A., et al. Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 116 (2010), 544–573.
3. 3 Siegel, R.L., Jemal, A., Ward, E.M., Increase in incidence of colorectal cancer among young men and women in the United States. Cancer Epidemiol Biomarkers Prev 18 (2009), 1695–1698.
4. 4 Abdelsattar, Z.M., Wong, S.L., Regenbogen, S.E., et al. Colorectal cancer outcomes and treatment patterns in patients too young for average-risk screening. Cancer 122 (2016), 929–934.
5. 5 Bailey, C.E., Hu, C.Y., You, Y.N., et al. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975–2010. JAMA Surg 150 (2015), 17–22.
6. 6 Couric, K., An unexpected turn: my life as a cancer advocate. Am J Gastroenterol 111 (2016), 594–595.
7. 7 Quah, H.M., Joseph, R., Schrag, D., et al. Young age influences treatment but not outcome of colon cancer. Ann Surg Oncol 14 (2007), 2759–2765.
8. 8 O'Connell, J.B., Maggard, M.A., Liu, J.H., et al. Do young colon cancer patients have worse outcomes?. World J Surg 28 (2004), 558–562.
9. 9 Amri, R., Bordeianou, L.G., Berger, D.L., The conundrum of the young colon cancer patient. Surgery 158 (2015), 1696–1703.
10. 10 You, Y.N., Xing, Y., Feig, B.W., et al. Young-onset colorectal cancer: is it time to pay attention?. Arch Intern Med 172 (2012), 287–289.
11. 11 Tezcan, G., Tunca, B., Ak, S., et al. Molecular approach to genetic and epigenetic pathogenesis of early-onset colorectal cancer. World J Gastrointest Oncol 8 (2016), 83–98.
12. 12 Chang, D.T., Pai, R.K., Rybicki, L.A., et al. Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features. Mod Pathol 25 (2012), 1128–1139.
13. 13 Goel, G., Evolving role of gene expression signatures as biomarkers in early-stage colon cancer. J Gastrointest Cancer 45 (2014), 399–404.
14. 14 Limburg, P.J., Harmsen, W.S., Chen, H.H., et al. Prevalence of alterations in DNA mismatch repair genes in patients with young-onset colorectal cancer. Clin Gastroenterol Hepatol 9 (2011), 497–502.
15. 15 Vilar, E., Tabernero, J., Gruber, S.B., Micromanaging the classification of colon cancer: the role of the microRNAome. Clin Cancer Res 17 (2011), 7207–7209.
16. 16 Ciarrocchi, A., Amicucci, G., Sporadic carcinoma of the colon-rectum in young patients: a distinct disease? A critical review. J Gastrointest Cancer 44 (2013), 264–269.
17. 17 Mork, M.E., You, Y.N., Ying, J., et al. High prevalence of hereditary cancer syndromes in adolescents and young adults with colorectal cancer. J Clin Oncol 33 (2015), 3544–3549.
18. 18 Ben-Ishay, O., Brauner, E., Peled, Z., et al. Diagnosis of colon cancer differs in younger versus older patients despite similar complaints. Isr Med Assoc J 15 (2013), 284–287.
19. 19 Deng, S.X., An, W., Gao, J., et al. Factors influencing diagnosis of colorectal cancer: a hospital-based survey in China. J Dig Dis 13 (2012), 517–524.
20. 20 Dozois, E.J., Boardman, L.A., Suwanthanma, W., et al. Young-onset colorectal cancer in patients with no known genetic predisposition: can we increase early recognition and improve outcome?. Medicine (Baltimore) 87 (2008), 259–263.
21. 21 Esteva, M., Leiva, A., Ramos, M., et al. Factors related with symptom duration until diagnosis and treatment of symptomatic colorectal cancer. BMC Cancer, 13, 2013, 87.
22. 22 Rahman, R., Schmaltz, C., Jackson, C.S., et al. Increased risk for colorectal cancer under age 50 in racial and ethnic minorities living in the United States. Cancer Med 4 (2015), 1863–1870.
23. 23 Agresti, A., Categorical data analysis. Second edition, 2002, John Wiley & Sons, Inc., Hoboken, NJ.
24. 24 Esteva, M., Ruiz, A., Ramos, M., et al. Age differences in presentation, diagnosis pathway and management of colorectal cancer. Cancer Epidemiol 38 (2014), 346–353.
25. 25 Ahnen, D.J., Wade, S.W., Jones, W.F., et al. The increasing incidence of young-onset colorectal cancer: a call to action. Mayo Clin Proc 89 (2014), 216–224.
26. 26 Torring, M.L., Frydenberg, M., Hansen, R.P., et al. Time to diagnosis and mortality in colorectal cancer: a cohort study in primary care. Br J Cancer 104 (2011), 934–940.
27. 27 Bleyer, A., Barr, R., Hayes-Lattin, B., et al. The distinctive biology of cancer in adolescents and young adults. Nat Rev Cancer 8 (2008), 288–298.
28. 28 Ballester, V., Rashtak, S., Boardman, L., Clinical and molecular features of young-onset colorectal cancer. World J Gastroenterol 22 (2016), 1736–1744.
29. 29 Goldvaser, H., Purim, O., Kundel, Y., et al. Colorectal cancer in young patients: is it a distinct clinical entity?. Int J Clin Oncol 21 (2016), 684–695.
30. 30 Antelo, M., Balaguer, F., Shia, J., et al. A high degree of LINE-1 hypomethylation is a unique feature of early-onset colorectal cancer. PLoS One, 7, 2012, e45357.
31. 31 Wattacheril, J., Kramer, J.R., Richardson, P., et al. Lagtimes in diagnosis and treatment of colorectal cancer: determinants and association with cancer stage and survival. Aliment Pharmacol Ther 28 (2008), 1166–1174.
32. 32 Taylor, D.P., Burt, R.W., Williams, M.S., et al. Population-based family history-specific risks for colorectal cancer: a constellation approach. Gastroenterology 138 (2010), 877–885.
33. 33 Lowery, J.T., Ahnen, D.J., Schroy, P.C. 3rd, et al. Understanding the contribution of family history to colorectal cancer risk and its clinical implications: a state-of-the-science review. Cancer 122 (2016), 2633–2645.
34. 34 Myer, P.A., Mannalithara, A., Singh, G., et al. Clinical and economic burden of emergency department visits due to gastrointestinal diseases in the United States. Am J Gastroenterol 108 (2013), 1496–1507.